Strong associations have been repeatedly found between genetic polymorphisms of ANXA11 and sarcoidosis, a systemic immune disorder characterized by destructive, noncaseating epithelioid granulomatous lesions (i.e., nodules caused by inflammation that do not lead to cell death) [60–62]. Here, ANXA11 is linked to immune system disorder.